BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Mergers & acquisitions

  Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition

  The acquisition of breakout obesity star Metsera should pump new life into Pfizer’s portfolio, which over the last two years has suffered from three discontinued assets.

  September 22, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  September 22, 2025

   · 

  5 min read
• Press Releases

  BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

  September 22, 2025

   · 

  3 min read
• 

  Multiple sclerosis

  FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December

  The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s application package convinced the agency to take more time to review.

  September 22, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky